Mandanol

Paracetamol, the active ingredient in Mandanol, is an analgesic presented as an oral tablet for oral use. It reduces fever and relieves mild to moderate pain in adults and children, and is commonly employed in self‑medication. GNH USA supplies Mandanol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Paracetamol is used to manage fever and mild to moderate pain across several common conditions.

- Fever: lowers elevated body temperature. - Headache: alleviates tension‑type headache. - Muscular pain: eases sore muscles. - Dental pain: provides relief after dental procedures. - Cold/flu symptoms: helps control discomfort associated with viral upper respiratory infections.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea - Rash - Headache

Serious or Rare Side Effects: - Hepatotoxicity - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Anaphylaxis

When using Mandanol, consider the following precautions: - Dose adjustment: Use the lowest effective dose for the shortest duration. - Liver function: Avoid use in patients with severe hepatic impairment or active liver disease. - Alcohol consumption: Limit alcohol intake while using the product to reduce risk of liver injury. - Concomitant medications: Review use of other paracetamol‑containing products to prevent overdose. - Store at ambient temperature: Keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Paracetamol may interact with other medicines; monitor the following:

Major Interactions (Avoid): - Concurrent use with other paracetamol‑containing medicines: risk of overdose and hepatotoxicity. - Co‑administration with strong enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce analgesic effect.

Moderate Interactions (Monitor Closely): - Warfarin: paracetamol may enhance anticoagulant effect; monitor INR. - Alcohol: combined use increases liver toxicity risk. - Isoniazid: may increase risk of liver injury; monitor liver function.